An opioid therapy clinic in Vermont
Jordan Silverman/Getty
Early in August, the US Meals and Drug Administration (FDA) accepted a sixth treatment for reversing opioid overdoses. The product, name Zurnai, is an computerized injection of the drug nalmefene, produced by Purdue Pharma – the identical pharmaceutical firm that helped gasoline the opioid disaster.
Irony apart, that is – at the least at face worth – a welcome addition to the rising arsenal of medicines meant to fight the opioid disaster. Nalmefene is stronger and has an extended period than its extra frequent counterpart naloxone, which has turn out to be much less efficient towards an…
